Tyman Regulatory News (TYMN)

LUPUS CAPITAL PLC

("Lupus" or "the Group" or "the Company")

Appointment of Non-Executive Director

Lupus Capital plc, a leading international supplier of building products to the door and window industry, announces the appointment of Dr. Angelika Westerwelle to the Board of Directors of the Company as an additional independent non-executive Director with effect from 30th November 2012.

Dr. Westerwelle (aged 50), a German national, is the managing director of PPG-Pet Products GmbH, a joint venture of five Euro-Asian companies in the pet accessory market. She is also the managing partner of Lanax Management GmbH, an investment and consulting company. She acts as non-executive director of Pinova Capital GmbH and is a member of the German Monopolies Commission.

Angelika has extensive operational experience, including her previous roles in mid-sized engineering companies as CEO of RMG Regel-und Messtechnik GmbH and as Managing Director of the Weidemann Group. She has also worked as a management consultant for several years with The Boston Consulting Group and Alix Partners GmbH.

Angelika graduated from the University of Aachen, earned a graduate degree from Cambridge University and a Master of Public Administration from Harvard University. She later received her Doctorate in Economics from the Aachen Institute of Technology.

Angelika will sit on the Audit, Remuneration and Nominations Committees.

No further disclosures are required under Schedule 2(g) of the AIM Rules for Companies.

Commenting on the appointment, Jamie Pike, Chairman of Lupus Capital plc said:

"We are delighted to welcome Angelika to the Board. Her extensive experience in international manufacturing and in developing medium sized businesses will be of great benefit to Lupus as we continue to build the group into a leading international supplier of building products to the door and window industry."